We are live on ! Find out more
CAPR icon

Capricor Therapeutics
CAPR

16 hedge funds and large institutions have $2.44M invested in Capricor Therapeutics in 2019 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

764% more capital invested

Capital invested by funds: $283K → $2.44M (+$2.16M)

400% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 1

33% more funds holding

Funds holding: 12 → 16 (+4)

2.45% more ownership

Funds ownership: 2.46% → 4.91% (+2.4%)

50% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 4

Holders
16
Holders Change
+4
Holders Change %
+33.33%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
2
Reduced
4
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Royal London Asset Management
Royal London Asset Management
United Kingdom
+$207K
2
Renaissance Technologies
Renaissance Technologies
New York
+$140K
3
IAA
Independent Advisor Alliance
North Carolina
+$51.9K
4
Morgan Stanley
Morgan Stanley
New York
+$11.6K
5
Victory Capital Management
Victory Capital Management
Texas
+$1.57K

Top Sellers

1
Brown Advisory
Brown Advisory
Maryland
-$69K
2
Bank of America
Bank of America
North Carolina
-$1.12K
3
CBA
Coastal Bridge Advisors
Connecticut
-$446
4
HIIFS
Harel Insurance Investments & Financial Services
Israel
-$24
5
Vanguard Group
Vanguard Group
Pennsylvania
-$7
Name Holding Trade Value Shares
Change 		Change in
Stake
Royal London Asset Management
1
Royal London Asset Management
United Kingdom
$1.98M +$207K +59,839 New
Renaissance Technologies
2
Renaissance Technologies
New York
$150K +$140K +40,513 New
Vanguard Group
3
Vanguard Group
Pennsylvania
$111K -$7 -2 -0%
IAA
4
Independent Advisor Alliance
North Carolina
$56K +$51.9K +15,000 New
Geode Capital Management
5
Geode Capital Management
Massachusetts
$48K – – –
CBA
6
Coastal Bridge Advisors
Connecticut
$40K -$446 -129 -1%
US Bancorp
7
US Bancorp
Minnesota
$28K – – –
Morgan Stanley
8
Morgan Stanley
New York
$13K +$11.6K +3,346 +4,780%
HIIFS
9
Harel Insurance Investments & Financial Services
Israel
$3K -$24 -7 -1%
Royal Bank of Canada
10
Royal Bank of Canada
Ontario, Canada
$3K – – –
BlackRock
11
BlackRock
New York
$2K +$3 +1 +0.2%
Victory Capital Management
12
Victory Capital Management
Texas
$2K +$1.57K +454 New
Bank of America
13
Bank of America
North Carolina
$1K -$1.12K -323 -54%
CFN
14
Cordasco Financial Network
Florida
$1K – – –
LTFS
15
Ladenburg Thalmann Financial Services
Florida
$1K – – –
UBS Group
16
UBS Group
Switzerland
$1K +$879 +254 New
Brown Advisory
17
Brown Advisory
Maryland
– -$69K -20,692 Closed

CAPR Hedge Fund Activity: Q3 2019 in Review

16 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Capricor Therapeutics (CAPR) for Q3 2019, worth a combined $2.44M — up 764% from $283K a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new CAPR positions and 1 closed out — a net gain of 4 holders — while 2 added to existing stakes and 4 trimmed.

The largest buyer was Royal London Asset Management, opening a new position worth an estimated $207K. The largest seller was Brown Advisory, exiting entirely with an estimated $69K sold.

  • 16 institutional investors held Capricor Therapeutics (CAPR) as of Q3 2019, up from 12 in Q2 2019.
  • Funds reported $2.44M of Capricor Therapeutics stock for Q3 2019, up 764% quarter-over-quarter.
  • 5 funds opened new Capricor Therapeutics positions in Q3 2019 and 1 closed out, a net change of +4 holders.
  • The largest Capricor Therapeutics buyer in Q3 2019 was Royal London Asset Management, an estimated $207K added.
  • The largest Capricor Therapeutics seller in Q3 2019 was Brown Advisory, an estimated $69K sold.

Based on aggregated 13F filings for Q3 2019.